A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Annals of Neurology
To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants.doi:10.1002/ana.25333 pmid:30255971 pmcid:PMC6354051 fatcat:7x3fos5xzzbc5fphv5aq4uavxm